Immunotherapy of Malignant Melanoma
- 26 March 2014
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert reviewCritical Reviews in Oncology/Hematology, 2013
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Immunologic Correlates of the Abscopal Effect in a Patient with MelanomaNew England Journal of Medicine, 2012
- Delving into somatic variation in sporadic melanomaPigment Cell & Melanoma Research, 2012
- A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic MelanomaClinical Cancer Research, 2011
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer ImmunotherapyClinical Cancer Research, 2011
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced MelanomaNew England Journal of Medicine, 2011
- VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 SignalingMolecular Therapy, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010